InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Introduction: Financing through understanding

IP's intangible nature does little to bolster investor confidence in biotechnology. Roya Ghafele, who works as an economist at WIPO, says that biotechnology is insufficiently funded due to a lack of awareness of the value of patents among both borrowers and investors

Intangibles such as patents have historically been treated as if they were invisible, and irrelevant to individual business performance. So capital markets tended to punish research-intensive companies, which are common in biotechnology.

New growth theory explains that economic growth is...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null

null null null


January / February 2019

IP STARS rankings 2019: Top firms for trade mark work

Managing Intellectual Property is delighted to publish the IP STARS 2019 rankings of the leading firms for trade mark work. This is the first set of results from the research for IP STARS 2019, which started in September 2018.

Most read articles